This trial is to see if the PATH program is feasible and acceptable to help improve quality of life for those who have undergone stem cell transplant for blood cancer treatment.
2 Primary · 1 Secondary · Reporting Duration: At baseline (registration) and then week 9 (+/- 1 week) and week 18 (+/- 1 week) from the time of registration
Active Control
Experimental Treatment
70 Total Participants · 2 Treatment Groups
Primary Treatment: Positive Psychology Intervention · No Placebo Group · N/A
Age 18 - 90 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: